J. Sculier (Brussels, Belgium), P. E. Postmus (Amsterdam, The Netherlands)
Patient and doctor delay in the diagnosis and treatment of lung cancer
A. S. Yurdakul, A. Bingul, J. Karakaya, C. Ozturk (Ankara, Turkey)
|  |
An audit on an assistance pathway of the lung tumor
C. M. Carbonelli, R. Toffanetti, L. Agostini, L. Zucchi (Reggio Emilia, Italy)
| |
Multi-disciplinary team working in lung cancer; nature and outcome of discussions
S. Tan, S. Ashenford, J. McAdam, D. Evanson, K. Srinivasan, H. Moudgil (Telford, United Kingdom)
| |
Lung cancer treatment strategies in a district general hospital
A. Aziz, H. S. R. Hosker (Keighley, United Kingdom)
| |
Management of 209 patients with lung cancer in the pulmonary department of the 1st medical faculty in Prague – smoking status and resecability
M. Marel, P. Stranska, O. Mericka, Z. Skacel, F. Krejbich, J. Homolka, M. Zemanova (Prague, Czech Republic)
| |
The terms of adaptation of functional systems of patients with lung cancer and secondary inflammatory changes after surgical treatment
Y. N. Schanin, O. B. Ilina, I. M. Kuznetsov (St Petersburg, Russian Federation)
| |
Surgically resected bronchioloalveolar carcinoma – T-status, N-status, pTNM stage and survival
Y. G. Slavova, D. Petrov, V. Djambazov, Z. Valerianova, V. Vlasov, V. Stanoev, D. M. Marinova (Sofia, Bulgaria)
| |
Surgical treatment of pulmonary metastasis
A. V. Reshetov, P. K. Yablonsky, F. M. Markin (Saint-Petersburg, Russian Federation)
| |
Survival and clinico-pathologic prognostic factors in surgically resected non-small cell lung carcinoma
Y. G. Slavova, W. Olszewski, D. Petrov, Z. G. Valerianova, S. S. Nachev, V. Stanoev (Sofia, Bulgaria; Warsaw, Poland)
| |
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Y. N. Shanin, O. B. Ilina, I. M. Kuznetsov (St Petersburg, Russian Federation)
| |
Is prophylactic radiotherapy at intervention site always neccessary in malign pleural mesothelioma?
S. Parspour, M. Metintas, G. Ak, H. Yildirim, E. Dundar (Eskisehir, Turkey)
| |
Symptom control and objective response due to palliative therapy of NSCLC brain metastases – 68 cases
D. M. Jovanovic, M. Velinovic, S. Popevic, D. Maric, L. Nagorni-Obradovic, R. Stevic, V. Skodric-Trifunovic, S. Radovanovic (Belgrade, Serbia And Montenegro)
| |
Management of lung cancer in the elderly
T. F. P. McKeagney, B. Hamilton, N. Chapman, R. P. Covery (Craigavon, United Kingdom)
| |
Chemotherapy with oral vinorelbine for geriatric patients with advanced non-small cell lung cancer – preliminary results
I. Spasova, R. Davidova, S. Csemyova, J. Musil (Prague, Czech Republic)
| |
The effectiveness of vinorelbine plus cisplatin versus gemcitabine plus cisplatin in local advanced non small cell lung cancer
B. Komurcuoglu, H. Aydogan, S. Tekgul, E. Yalniz, E. Ozden (Izmir, Turkey)
| |
Metastatic lung cancer: a case followed for 15 years
E. Kunter, G. Kandemir, O. Turken, B. Karagoz, O. Bilgi, T. Isitmangil (Istanbul, Turkey)
| |
Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
E. M. Mannion, D. Waldron, J. J. Gilmartin (Galway, Ireland)
| |
Changes in body compositon in men and women with advanced non-small cell lung cancer (NSCLC) undergoing chemotherapy
M. Petrovic, I. Tomic, I. Jevtovic, Z. Lazic, I. Cekerevac, L. Novkovic, S. Mojsilovic (Kragujevac, Belgrade, Serbia And Montenegro)
| |
Oral etoposide-induced leucocytoclastic vasculitis in a patient with lung carcinoma
E. Kunter, O. Turken, B. Karagoz, O. Bilgi, B. Dogan, G. Kandemir (Istanbul, Turkey)
| |
Neutropenia in lung cancer cases after chemotherapy
I. Karasu, S. Ayik, A. Ozsoz, A. Cakan (Izmir, Turkey)
| |
Gemcitabine induced pulmonary toxicity in a single patient: case report
A. Gorek, S. Ozturk, G. Ulubay, S. Akcay, F. O. Eyubogu (Ankara, Turkey)
| |
Thrombophlebitis, MTHFR polymorphism and pemetrexed-based chemotherapy
C. Barnig, B. Mennecier, E. Andres, E. Quoix (Strasbourg, France)
| |
The results of gefitinib (Iressa) treatment in 89 patients with advanced non-small cell lung cancer (NSCLC) on expanded access programme (EAP)
J. Skrickova, M. Tomiskova, A. Svobodnik, L. Babickova, J. Kaplanova, T. Nebesky, D. Stratil (Brno, Czech Republic)
| |
Response to targeted therapy in a 68-year-old male smoker with a squamous cell lung cancer treated with an epidermal growth factor receptor antagonist
I. Stehle, A. Groeschel, G. W. Sybrecht (Homburg/Saar, Germany)
| |
Efficacy and safety of talc pleurodesis in patients with malignant pleural effusions
H. Yildirim, M. Metintas, G. Ak, S. Erginel, E. Kurt, F. Alatas, I. Ucgun (Eskisehir, Turkey)
| |
Thoracoscopic talc poudrage versus povidone-iodine for pleurodesis of effusion due to metastatic breast cancer
T. A. Mohsen, A. A. Abou Zeid (Cairo, Egypt)
| |
Pemetrexed (alimta) therapy in mesothelioma
O. Turan, A. Hayretdag, S. Bulac, A. Akkoclu, E. Osma (Izmir, Turkey)
| |
Malignant pericardial effusion in lung cancer patients
T. Adzic, S. Filipovic, N. Samardzic, S. Popevic, D. Trifunovic, V. Djukanovic (Belgrade, Serbia And Montenegro)
| |
Endovascular stenting of superior vena cava syndrom
K. Czebe, K. Fuzesi, B. Nemes, K. Huttl, E. Csiszer (Budapest, Hungary)
| |
Sucessful fiberoptic bronchoscopic removal of polypoid endotracheal metastasis of ovarian carcinoma
M. J. Park, H. S. Choi, C. W. Choi, J. H. You, H. M. Kang (Seoul, Republic Of Korea)
| |
Are biphosphonates efficient in the adjuvant treatment of lung cancer?
F. Vlastos, N. Cassou, C. Clement-Duchene, C. Carnin, N. Martinet, Y. Martinet (Athens, Greece; Vandoeuvre les Nancy, Nancy, France)
| |
Daily vs weekly administration of epoetin- beta for the control of lung cancer – related anaemia after combination chemoterapy in patients with NSCCL (stage IIIa, IIIb and IV)
S. D. Ecaterini, F. L. Manolis, M. D. George, T. N. Elisavet, P. M. George, G. Polixeni, B. C. Nikolaos (Heraklion, Greece)
| |
Radical radiotherapy alone in medically inoperable early stage I non small cell lung cancer
N. P. Jovanovic Korda (Belgrade, Serbia And Montenegro)
| |
Whole brain radiotherapy for brain – only metastases of small cell lung cancer
N. P. Jovanovic Korda (Belgrade, Serbia And Montenegro)
| |
The effects of different chemotherapy regimes in the patients with advanced lung cancer
A. S. Yurdakul, C. Ozturk, D. Taskin, A. Varol, J. Karakaya (Ankara, Turkey)
| |
The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer
O. Tuzel, B. Komurcuoglu, M. Gayaf, G. Tibet (Izmir, Turkey)
| |
Cancer recurrence in surgically treated non small cell lung cancer (NSCLC)
V. Kacar-Kukric, S. Popevic (Belgrade, Serbia And Montenegro)
| |